Tadayoshi Yasui is the founder of ENU Pharma. ENU Pharma has raised $1M in total funding. Latest round: Seed.
Tadayoshi Yasui is the CEO of ENU Pharma, a company based in Sapporo, Japan. Founded in December 2019, ENU Pharma specializes in the research and development of glycopeptide-specific therapeutic antibodies. The company focuses on detecting abnormal glycans and creating precision glycopeptide recognition antibodies for conditions like liver and pancreatic cancer, and autoimmune diseases. ENU Pharma has secured a seed round investment of 200 million yen from Innovation Kyoto 2021 Investment Limited Partnership.
Full founder directory · Investor directory · Company funding database · Fundraising library